Peripheral Nerve Stimulators Healthy Pace throughout the Forecast during 2026Posted by Shirish Wadaskar on November 21st, 2019
With the Food and Drug Administration (FDA) recently clearing two neurostimulation devices- SPRINT endura and extensa, for treating acute and chronic pain, the future landscape for peripheral nerve stimulators (PNS) looks promising. As per a recently released in-depth study by Persistence Market Research (PMR), the global peripheral nerve stimulator market is projected to represent a robust year on year revenue growth of approximately 6.9 percent in 2019. The global peripheral nerve stimulator market is expected to reach a valuation of US$ 375.9 Million, during the same period. To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/18982 In addition, current advancements in the peripheral nerve stimulators would gradually increase the demand for treating a host of chronic pain conditions arising from cranial neuralgias and peripheral nerve dysfunctions. Apart from their implantation being minimally invasive, the new variants of peripheral nerve stimulators also allow externally-placed pulse generators to wirelessly transmit impulses to the implanted electrode. Moreover, miniaturization of neuromodulation devices and ultrasound-guided, minimally invasive implantation technique are some notable advancements, likely to shift the spotlight on non-drug pain management solutions, such as peripheral nerve stimulators. Insights from Segmentation Analysis of Peripheral Nerve Stimulator Market
“Given the applicability of peripheral nerve stimulators as a targeted alternative for pain management systems as opposed to high dosages of medication affecting the entire body, key companies manufacturing peripheral nerve stimulators are making substantial investments in clinical studies to improve the quality of treatment and technology for nerve disorder-related devices. Advantages of peripheral nerve stimulator such as minimal or no side effects of administering neuromuscular blocking agents (NMBAs) along with integration of next-generation technology, is likely to shape the future of peripheral nerve stimulator”, Senior Analyst, Persistence Market Research To Get Extensive Insights On Key Trends, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/18982 PMR in its report on the global peripheral nerve stimulator landscape offers insights into the key developments and forward market strategies of top manufacturers of peripheral nerve stimulator. Companies are making novel innovations to specifically target peripheral nerve pain for patients who are not responsive to pharmacologic therapies. Key differentiation strategies adopted by key manufacturers include:
Like it? Share it!More by this author |